Tumor M2 pyruvate kinase--determination in breast cancer patients receiving trastuzumab therapy.

Hoopmann, Markus

Tumor M2 pyruvate kinase--determination in breast cancer patients receiving trastuzumab therapy. [electronic resource] - Cancer letters Dec 2002 - 223-8 p. digital

Publication Type: Journal Article

0304-3835

10.1016/s0304-3835(02)00404-4 doi


Adenocarcinoma--drug therapy
Adult
Aged
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--therapeutic use
Biomarkers, Tumor--blood
Breast Neoplasms--drug therapy
Female
Humans
Middle Aged
Mucin-1--metabolism
Neoplasm Staging
Prognosis
Pyruvate Kinase--blood
Receptor, ErbB-2--metabolism
Receptors, Estrogen--metabolism
Receptors, Progesterone--metabolism
Retrospective Studies
Trastuzumab
Treatment Outcome